Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)

Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)

Gespeichert in:

Bibliographische Detailangaben
Datum:	2020
Hauptverfasser:	M. V. Sadchykova, L. V. Syniavina, N. M. Otchenash
Format:	Artikel
Sprache:	English
Veröffentlicht:	2020
Schriftenreihe:	International medical journal
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0001126715
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Rational design of protein kinase inhibitors
von: S. M. Yarmoluk, et al.
Veröffentlicht: (2013)

Rational design of protein kinase inhibitors
von: Yarmoluk, S.M., et al.
Veröffentlicht: (2013)

Janus kinase inhibitors in dermatology: present and future
von: I. M. Serbina, et al.
Veröffentlicht: (2021)

Quinazoline inhibitors of protein kinase FGFR1
von: A. A. Hryshchenko, et al.
Veröffentlicht: (2010)

Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
von: Maur, D., et al.
Veröffentlicht: (2009)

Impact of combinations of EGF, TGF?, 17?-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
von: M. Mints, et al.
Veröffentlicht: (2014)

Algorithm of treatment of patients with breast cancer with metastatic defeat of bones: review of literature and clinical case
von: O. V. Ponomareva, et al.
Veröffentlicht: (2015)

Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
von: Mints, M., et al.
Veröffentlicht: (2014)

An inhibitor of Ca2+-dependent protein kinases, trifluoperazine, increases the efficiency of agrobacterium-mediated transformation of tobacco
von: V. V. Fedorchuk, et al.
Veröffentlicht: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: I. G. Tkalia, et al.
Veröffentlicht: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
von: V. Fedorchuk, et al.
Veröffentlicht: (2015)

Cell cycle regulators in Arabidopsis thaliana (Brassicaceae) transgenic plants under clinorotation. Cyclin-depending kinases
von: O. A. Artemenko
Veröffentlicht: (2014)

Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazineinduced colorectal carcinogenesis of rats
von: I. V. Bielinska, et al.
Veröffentlicht: (2014)

Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
von: Ya. A. Sheremet, et al.
Veröffentlicht: (2012)

Evaluation of 4H-4-chromenone derivatives as inhibitors of protein kinase CK2
von: Prykhodko, A.O., et al.
Veröffentlicht: (2005)

Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
von: Sheremet, Ya.A., et al.
Veröffentlicht: (2012)

The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
von: Liubota, R., et al.
Veröffentlicht: (2017)

Search of protein kinase CK2 inhibitors based on purine-2,6-diones derivatives
von: M. V. Protopopov, et al.
Veröffentlicht: (2017)

Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
von: Q. Zhang, et al.
Veröffentlicht: (2015)

Inhibitors of tyrosine kinases and phosphatases as a tool for the investigation of microtubule role in plant cold response
von: Ya. A. Sheremet, et al.
Veröffentlicht: (2012)

Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
von: Zhang, Q., et al.
Veröffentlicht: (2015)

Inhibitors of tyrosine kinases and phosphatases as a tool for the investigation of microtubule role in plant cold response
von: Sheremet, Ya.A., et al.
Veröffentlicht: (2012)

Effect of glutamine or glucose deprivation on the expression of cyclin and cyclin-dependent kinase genes in glioma cell line U87 and its subline with suppressed activity of signalling enzyme of endoplasmic reticulum–nuclei-1
von: D. O. Minchenko, et al.
Veröffentlicht: (2011)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
von: J. Zekri, et al.
Veröffentlicht: (2015)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
von: Zekri, J., et al.
Veröffentlicht: (2015)

Male breast cancer: clinical presentation, diagnosis, treatment
von: Y. S. Hotko
Veröffentlicht: (2013)

Male breast cancer: clinical presentation, diagnosis, treatment
von: Hotko, Y.S.
Veröffentlicht: (2013)

Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco BY-2 cells
von: Ja. A. Sheremet, et al.
Veröffentlicht: (2012)

Effect of protein kinase CK2 inhibitors on its catalytic subunits SK2α and SK2α´
von: O. V. Ostrynska, et al.
Veröffentlicht: (2014)

Protein inhibitors synthesised by microorganisms
von: E. V. Matseljukh, et al.
Veröffentlicht: (2013)

Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
von: A. N. Dubinina
Veröffentlicht: (2016)

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
von: I. O. Zhaleiko, et al.
Veröffentlicht: (2014)

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
von: Zhaleiko, I.O., et al.
Veröffentlicht: (2014)

Deletions in metastatic colorectal cancer with chromothripsis
von: Skuja, E., et al.
Veröffentlicht: (2023)

Clinical course of Paget's breast cancer at organ-preserving surgery
von: L. V. Sinjavina, et al.
Veröffentlicht: (2017)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy
von: J. Lakota, et al.
Veröffentlicht: (2015)

Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy
von: Lakota, J., et al.
Veröffentlicht: (2015)